Chris Tauer
Chief Financial Officer
Senior Management Team
Syntrix Biosystems
United States of America
Biography
He started working at MediChem Life Sciences, a drug discovery and technology company, in a finance role when he graduated from college. deCODE Genetics acquired MediChem three years later, and he stayed on as vice president of finance at the Icelandic company’s U.S. office. Later, He became chief financial officer of Emerald Bio when the company spun out from deCODE in 2009, and He continue to hold this role at Beryllium. He have a bachelor’s degree in accounting from Eastern Illinois University.
Research Interest
Drug discovery
